Keynote Presentations

Wybo Dondorp 

Aim and Scope of Prenatal Screening: The Autonomy Paradigm and Its Limits

Wybo Dondorp, Ph.D., Maastricht University

Darren Griffin 

25 Years of Chromosomal PGD and Counting

Darren K. Griffin, Ph.D., DSc, University of Kent

Ulf Goebel 

Hurricane Watch: Use of Novel Technologies for Early Detection and Identification of Multi-Resistant Bacteria

Ulf B. Goebel, M.D., Ph.D., Charité, University Medicine Berlin

Wilfried von Eiff 

Impact of POCT Technology on Efficiency and Effectiveness of Clinical Processes

Wilfried von Eiff, Ph.D., Leipzig Graduate School of Management

Klaus Pantel 

Clinical Implications of CTCs Analysis

Klaus Pantel, M.D., University Medical Center Hamburg-Eppendorf

Mike Makrigiorgos 

Novel Methods for Enrichment of Mutations and Differentially Methylated Sequences from Liquid Biopsy Genomes

G. Mike Makrigiorgos, Ph.D., Dana Farber and Harvard Medical School

Novel molecular-based tools are rapidly entering the clinic and creating a new paradigm in healthcare. The Fourth International Molecular Diagnostics Europe event will return to Lisbon this spring and feature six tracks: Prenatal Molecular Diagnostics, Reproductive Genetic Diagnostics, Circulating Tumour Cells, Circulating Cell-Free DNA, Advanced Diagnostics for Infectious Disease, and Point-of-Care Diagnostics. As the prenatal diagnostics market has demonstrated, molecular diagnostics are being applied to the clinical setting for greater speed and accuracy of healthcare delivery, while paving the way for a new era in medicine.